Accelerated Phase Chronic Myelogenous Leukemia Completed Phase 1 Trials for 7-Hydroxystaurosporine (DB01933)

IndicationStatusPhase
DBCOND0028985 (Accelerated Phase Chronic Myelogenous Leukemia)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT003019387-Hydroxystaurosporine and Perifosine in Treating Patients With Relapsed or Refractory Acute Leukemia, Chronic Myelogenous Leukemia or High Risk Myelodysplastic SyndromesTreatment